Related references
Note: Only part of the references are listed.Combination of non-vitamin K antagonist oral anticoagulants and antiepileptic drugs
Semiha Kurt et al.
EUROPEAN HEART JOURNAL (2019)
The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data
Massimiliano Buoli et al.
DRUGS IN R&D (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare
U. Budde et al.
Hamostaseologie (2018)
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
Andreas Zirlik et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
Shang-Hung Chang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Assessment of the coding accuracy of warfarin-related bleeding events
Thomas Delate et al.
THROMBOSIS RESEARCH (2017)
Patterns of antiepileptic drug prescription in Sweden: A register-based approach
K. Bolin et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs
Claudia Stoellberger et al.
EPILEPSY RESEARCH (2016)
The Use of Antiepileptics in Migraine Prophylaxis
Francesca Bagnato et al.
HEADACHE (2016)
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
Yi-Hsin Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients
Oh Young Bang et al.
JOURNAL OF STROKE (2014)
Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review
Hai-Fei Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
Lars Hvilsted Rasmussen et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Antiepileptic drugs in the treatment of psychiatric disorders
Kenneth R. Kaufman
EPILEPSY & BEHAVIOR (2011)
Antiepileptic drugs modulate P-glycoproteins in the brain: A mice study with 11C-desmethylloperamide
Lieselotte Moerman et al.
EPILEPSY RESEARCH (2011)
New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?
Jacqueline A. French et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetarn and carbamazepine by human and mouse P-glycoprotein
Steffen Baltes et al.
NEUROPHARMACOLOGY (2007)
Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats
H Potschka et al.
EPILEPSY RESEARCH (2004)
In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms:: preferential inhibition of cytochrome P4502C9 (CYP2C9)
X Wen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers
RH Levy et al.
EPILEPSY RESEARCH (2001)
Share Paper
